Company intelligence / Profile preview

Lightnix

Chuo-ku, Tokyo, Japan

Ownership: Private
Employees: ~141
Development stage: Other

Overview

Lightnix is a Japanese medical device company focused on environmentally friendly, low-pain puncture and injection technologies. The company developed and commercialized Pinnix Light, a plant-based resin lancet for blood sampling designed using a mosquito-inspired geometry to reduce pain and improve safety. It is also developing an intradermal vaccine administration device intended to support dose-sparing vaccination and lower-cost infectious disease prevention. Lightnix positions itself at the intersection of medtech, biomaterials, and preventive healthcare rather than therapeutics or drug development.

Therapeutic areas: OtherInfectious Diseases
Modalities: Device
Industry: Consumable Medical Devices

Beyond the preview

Go deeper on Lightnix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lightnix.

Explore the full profile